Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
MOONS'
How Artemis will help the U.S. create a moon base - NBC News
Agilent
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
FierceBiotech
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Thermo Fisher
Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals
Agilent
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Thermo Fisher
Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics Blog
Why 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
FierceBiotech
Kurma closes €215M Europe-focused fund to spread across 20 biotechs
FierceBiotech
Pfizer cans work on next-gen conjugate in cancer patients
BioWorld
Financings for April 23, 2026
BioWorld
In the clinic for April 23, 2026
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioWorld
Total
1081
Source
BioWorld
Recherche
--
BioWorld
8 janv. 2026
Inflarx focuses on izicopan as biopharma spending cuts continue
BioWorld
8 janv. 2026
Moonlake preps for sonelokimab BLA in HS; no new trials needed
BioWorld
8 janv. 2026
FDA rejects Vanda’s Hetlioz for jet lag disorder
BioWorld
8 janv. 2026
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
BioWorld
8 janv. 2026
Appeals court says no to cap on indirect costs in NIH grants
BioWorld
8 janv. 2026
Hetero Labs describes new tyrosine kinase inhibitors
BioWorld
8 janv. 2026
New 3CLpro inhibitors disclosed in Nxera Pharma patent
BioWorld
8 janv. 2026
Shanghai Huilun Pharmaceutical discovers new 5-HT2A receptor agonists
BioWorld
7 janv. 2026
Appointments and advancements for Jan. 7, 2026
BioWorld
7 janv. 2026
Financings for Jan. 7, 2026
BioWorld
7 janv. 2026
In the clinic for Jan. 7, 2026
BioWorld
7 janv. 2026
Other news to note for Jan. 7, 2026
BioWorld
7 janv. 2026
Regulatory actions for Jan. 7, 2026
BioWorld
7 janv. 2026
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
BioWorld
7 janv. 2026
New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent
BioWorld
7 janv. 2026
Chinese scientists discover new GTPase KRAS mutant inhibitors
BioWorld
7 janv. 2026
Holiday notice
BioWorld
6 janv. 2026
Appeals court says no to cap on indirect costs in NIH grants
Précédent
43 / 61
Suivant